- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.79 Å
- Oligo State
- monomer
- Ligands
- 1 x 6V3: 1-(4-((1H-pyrrolo[2,3-b]pyridin-4-yl)oxy)phenyl)-3-(5-(4-methylpiperazin-1-yl)naphthalen-2-yl)urea(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Muraoka, T. et al., Development of a Method for Converting a TAK1 Type I Inhibitor into a Type II or c-Helix-Out Inhibitor by Structure-Based Drug Design (SBDD). Chem.Pharm.Bull. (2016)
- Release Date
- 2016-11-16
- Peptides
- TAK1 kinase - TAB1 chimera fusion protein: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A